Candriam Equities L Life Care BF USD Inc Fonds
|
ISIN: LU2223682860
Anlageziel
The objective of the sub-fund is to benefit from the performance of the markets in equities of companies active in the pharmaceuticals, healthcare, medical technologies and biotechnology sectors, by investing in stocks of companies selected by the asset manager on the basis of their expected return, and to outperform the benchmark. This sub-fund invests primarily in equities, and/or securities equivalent to equities, of companies throughout the world which are active in the pharmaceuticals, healthcare, medical technologies and biotechnology sectors. It may also invest in companies with a high proportion of sales relating to the improvement of health conditions.
Stammdaten
WKN | |
ISIN | LU2223682860 |
Fondsgesellschaft | Candriam |
Kategorie | Branchen: Gesundheitswesen |
Währung | USD |
Mindestanlage | |
VL-fähig? | Nein |
Thesaurierend/Ausschüttend | Ausschüttend |
Fondsmanager | Servaas Michielssens, Pierre Vaurice, Rudi Van den Eynde |
Aktuelle Daten
Fondsnote | - |
Aktueller Rücknahmepreis | 1 501,13 |
Fondsvolumen | 808 138 196,18 |
Total Expense Ratio (TER) | 0,07 |
Gebühren
Verwaltungsgebühr | % |
Depotbankgebühr | % |
Rücknahmegebühr | 0,00 % |
Ausgabeaufschlag | 0,00 % |
Basisdaten
Auflagedatum | 11.12.2020 |
Depotbank | CACEIS Bank, Luxembourg Branch |
Zahlstelle | CACEIS Bank, Paris, succursale de Nyon / Suisse |
Domizil | Luxembourg |
Geschäftsjahr | 31.12.2024 |
Performancedaten
Veränderung Vortag | 17,07 |